Key points are not available for this paper at this time.
Objective Chemotherapy-induced peripheral neuropathy (CIPN) is a common and severe adverse reaction in taxane-based chemotherapy. This study aimed to analyze the risk factors of peripheral neuropathy in patients with breast cancer receiving paclitaxel chemotherapy to provide a reference for the early prevention of CIPN. Methods We included 350 patients with breast cancer who received chemotherapy for the first time at the Tangshan People’s Hospital between August 2022 and June 2023 and were followed for at least 3 months after the end of chemotherapy. The incidence of CIPN in patients with breast cancer was calculated, and risk factors for CIPN were analyzed using logistic regression analysis. Results The incidence rate of CIPN was 79.1%. Multifactor logistic regression analysis indicated that age ≥45 years odds ratio (OR)=5.119, 95% confidence interval (CI)=1.395–18.780 and ≥60 years (OR=9.366, 95% CI=1.228–71.421), history of hypertension (OR=3.475, 95% CI=1.073–11.250), cumulative dose of chemotherapy drugs 900 mg (OR=4.842, 95% CI=1.961–5.946), vitamin D deficiency (OR=6.214, 95% CI=2.308–16.729), abnormal alanine aminotransferase (OR=3.154, 95% CI=1.010–9.844), anemia before chemotherapy (OR=2.770, 95% CI=1.093–7.019), infusion duration of chemotherapy drugs 30 min (OR=3.673, 95% CI=1.414–9.539), body mass index ≥24 kg/m 2 (OR=8.139, 95% CI=1.157–57.240), mild depression (OR=4.546, 95% CI=1.358–15.223), and major depression (OR=4.455, 95% CI=1.237–16.037) increased the risk of CIPN. Having a regular caregiver (OR=0.223, 95% CI=0.087–0.573), high levels of physical activity (OR=0.071, 95% CI=0.008–0.647), and strong social support (OR=0.048, 95% CI=0.003–0.682) were protective factors against CIPN. Conclusion Clinical attention should be paid to patients with these risk factors, and active and effective preventive measures should be taken to reduce the occurrence of CIPN and improve the quality of life.
Building similarity graph...
Analyzing shared references across papers
Loading...
Lixian et al. (Thu,) studied this question.
synapsesocial.com/papers/68e7542bb6db6435876cbe66 — DOI: https://doi.org/10.3389/fonc.2024.1327318
Sun Lixian
North China University of Science and Technology
Xiaoqian Yu
North China University of Science and Technology
Guo Luyan
North China University of Science and Technology
Frontiers in Oncology
North China University of Science and Technology
Tangshan College
Kailuan General Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: